Safety of an Intravitreal Injection of Triamcinolone
Top Cited Papers
Open Access
- 1 March 2004
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 122 (3) , 336-340
- https://doi.org/10.1001/archopht.122.3.336
Abstract
Periocular and orbital injections of long-acting corticosteroids havebeen standard treatments for various inflammatory conditions of the eye formany years.1,2 Some authoritieshave proposed that peribulbar administration of corticosteroids might notbe ideal for the treatment of chronic ocular disease, suggesting that theiraction is partly due to systemic absorption of the drug and that their effectivedose lasts only a few days to weeks.3 Intraocularadministration of corticosteroids has the potential to give extended dosesof a drug at high local concentrations.Keywords
This publication has 10 references indexed in Scilit:
- Pseudo-endophthalmitis after intravitreal injection of triamcinoloneBritish Journal of Ophthalmology, 2003
- Uniocular macular oedema and reduced vision in a patient with uveitis.Clinical & Experimental Ophthalmology, 2000
- Intravitreal triamcinolone and elevated intraocular pressureAustralian and New Zealand Journal of Ophthalmology, 1999
- Biochemical Quantification of Triamcinolone in Subconjunctival DepotsArchives of Ophthalmology (1950), 1995
- Ocular Complications Associated with Retrobulbar InjectionsOphthalmology, 1988
- Clearance of Triamcinolone From VitreousArchives of Ophthalmology (1950), 1985
- The Clearance of Intravitreal Triamcinolone AcetonideAmerican Journal of Ophthalmology, 1982
- Increased Intraocular Pressure Induced by Repository CorticosteroidsAmerican Journal of Ophthalmology, 1976
- Bulbar Perforation During Periocular Injection of CorticosteroidsAmerican Journal of Ophthalmology, 1974
- Subconjunctival Triamcinolone Acetonide*American Journal of Ophthalmology, 1966